Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice

被引:54
|
作者
Chen, Shuang-qing [1 ]
Cai, Qing [1 ]
Shen, Yu-ying [1 ]
Wang, Pei-jun [2 ]
Teng, Gao-jun [3 ,4 ]
Zhang, Wei [2 ]
Zang, Feng-chao [4 ]
机构
[1] Nanjing Med Univ, Suzhou Hosp, Dept Radiol, Suzhou 215001, Jiangsu, Peoples R China
[2] Tongji Univ, Tongji Hosp, Dept Radiol, Shanghai 200065, Peoples R China
[3] Southeast Univ, Zhongda Hosp, Dept Radiol, Nanjing 210009, Jiangsu, Peoples R China
[4] Southeast Univ, Mol Imaging Laboratoryl, Nanjing 210009, Jiangsu, Peoples R China
关键词
Alzheimer's disease (AD); Magnetic resonance spectroscopy (MRS); Morris water maze (MWM); Metabolite; MAGNETIC-RESONANCE-SPECTROSCOPY; ALZHEIMERS-DISEASE; MOUSE-BRAIN; MR SPECTROSCOPY; AMYLOID-BETA; WATER MAZE; IN-VIVO; H-1; MRS; MODEL; DEFICITS;
D O I
10.1016/j.bbr.2012.07.016
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Proton magnetic resonance spectroscopy (H-1-MRS) and the Morris water maze (MWM) have played an important role in Alzheimer's disease (AD) research. The aim of this study was to determine whether H-1-MRS and the MWM can detect for early AD in APP/PS1 transgenic (tg) mice. H-1-MRS was performed in 20 tg mice and 15 wild-type mice at 3,5 and 8 months of age. The concentration of N-acetylaspartate (NAA), glutamate (Glu), myo-inositol (ml), choline (Cho) and creatine (Cr) in the hippocampus were measured, and the NAA/Cr. Glu/Cr, ml/Cr and Cho/Cr ratios were quantified. Additionally, the spatial learning and memory of the mice were evaluated by MWM. The H-1-MRS revealed that ml levels in tg mice were significantly higher at 3 months of age compared to wt mice, while the NAA and Glu levels in 5- and 8-month-old tg mice were significantly decreased (p < 0.05). Additionally, significant cognitive changes only occurred at 8 months of age in APP/PS1 tg mice. These results indicated that metabolic changes preceded overt cognitive dysfunctions in early-stage AD, suggesting that H-1-MRS is a more sensitive biomarker for assessing early AD. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice
    Xuying Li
    Fan Guo
    Qiaomei Zhang
    Tingting Huo
    Lixin Liu
    Haidong Wei
    Lize Xiong
    Qiang Wang
    BMC Complementary and Alternative Medicine, 14
  • [32] Dynamic changes in lysosome-related pathways in APP/PS1 mice with aging
    Xu, Zhendong
    Hu, Jichang
    Wei, Zhen
    Lei, Yu
    Afewerky, Henok Kessete
    Gao, Yang
    Wan, Lu
    Li, Longfei
    Lei, Ling
    Liu, Yi
    Huang, Fang
    Yu, Tong
    Wang, Jian-Zhi
    Li, Hong-Lian
    Liu, Rong
    Wang, Xiaochuan
    MEDCOMM, 2024, 5 (04):
  • [33] Xanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP/PS1 transgenic mice
    Zhu, Lin
    Chi, Tianyan
    Zhao, Xuemei
    Yang, Lei
    Song, Shijie
    Lu, Qiaohui
    Ji, Xuefei
    Liu, Peng
    Wang, Lihua
    Zou, Libo
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2018, 68 (05) : 555 - 565
  • [34] Chronic sleep deprivation exacerbates cognitive and synaptic plasticity impairments in APP/PS1 transgenic mice
    Wang, Chun
    Gao, Wen-Rui
    Yin, Jing
    Wang, Zhao-Jun
    Qi, Jin-Shun
    Cai, Hong-Yan
    Wu, Mei-Na
    BEHAVIOURAL BRAIN RESEARCH, 2021, 412
  • [35] Exercise Prevents Cognitive Function Decline and Demyelination in the White Matter of APP/PS1 Transgenic AD Mice
    Zhang, Lei
    Chao, Feng-Lei
    Luo, Yan-Min
    Xiao, Qian
    Jiang, Lin
    Zhou, Chun-Ni
    Zhang, Yi
    Lv, Fu-Lin
    He, Qi
    Ma, Jing
    Tang, Yong
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (06) : 645 - 655
  • [36] Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain
    Bin-bin Wei
    Ming-yan Liu
    Zai-xing Chen
    Min-jie Wei
    Acta Pharmacologica Sinica, 2018, 39 : 616 - 625
  • [37] Longitudinal behavioral changes in the APP/PS1 transgenic Alzheimer's Disease model
    Ferguson, Sherry A.
    Sarkar, Sumit
    Schmued, Larry C.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 242 : 125 - 134
  • [38] 1H-MRS Assessment of the Therapeutic Effect of Bilateral Intraventricular BDNF Infusion into APP/PS1 Double Transgenic Mice
    Zhang, Wei
    Wang, Pei-jun
    Li, Ming-hua
    Wang, Guo-liang
    Li, Ping
    Gao, Xiao-long
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 50 (03) : 434 - 442
  • [39] Protective signature of xanthohumol on cognitive function of APP/PS1 mice: a urine metabolomics approach by age
    Liu, Wei
    Chen, Xiao
    Zhao, Jing
    Yang, Chen
    Huang, Guanqin
    Zhang, Zhen
    Liu, Jianjun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [40] Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain
    Wei, Bin-bin
    Liu, Ming-yan
    Chen, Zai-xing
    Wei, Min-jie
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (04) : 616 - 625